Motegrity is a medicine for adults with long-lasting constipation that has no clear cause. It is taken as a pill. It works by helping the muscles in the bowel push stool along more often.
Every report comes from a Lived member, sent anonymously.
Have you tried Motegrity (Prucalopride) for Constipation?
Prucalopride, sold under the brand name Motegrity and also available as a generic, is a prescription tablet for adults with chronic idiopathic constipation. That term describes constipation that has lasted months or years without an identifiable cause, such as another illness or a medicine that slows the bowel. People with it typically have infrequent bowel movements, hard or lumpy stools, straining, or a sense that the bowel never fully empties. It is usually considered when fiber and over-the-counter laxatives have not worked well enough. Gastroenterology guidelines in the US strongly recommend it for that situation, either in place of those products or alongside them. It is not approved for children: a study in children and teenagers was stopped early because prucalopride worked no better than a placebo.
The bowel moves stool along through waves of muscle contraction that are partly coordinated by serotonin, a chemical messenger that acts on nerves in the gut wall. Prucalopride activates one type of serotonin receptor there, called 5-HT4. This prompts the gut's nerves to release signals that trigger strong, sweeping contractions in the colon, the kind that push stool toward the rectum. The result is more frequent, easier bowel movements. This makes it different from most laxatives, which work by drawing water into the stool or by irritating the bowel lining. Prucalopride targets the muscle movement itself, which is why it may help some people whose constipation has not responded to those products.
Prucalopride is taken by mouth once a day, with or without food. The usual adult dose is a 2 mg tablet. People with severe kidney impairment take a 1 mg tablet instead, because the kidneys clear most of the drug and it can build up when they work poorly. It is generally avoided in people on dialysis, and older adults may have their dose set according to kidney function. The tablets should be kept in their original container to protect them from moisture.
The most common side effects are headache, abdominal pain or cramping, nausea and diarrhea. Bloating, dizziness, vomiting, gas and tiredness are less frequent. Headache and diarrhea usually begin within the first day or two of treatment and, for most people, settle within a few days. About 5 in 100 people in the clinical trials stopped the medicine because of side effects, most often nausea or diarrhea. Diarrhea that is severe or does not ease after the first week is worth reporting to the prescriber. Allergic reactions are uncommon, but a rash, hives, swelling of the face or trouble breathing needs prompt medical attention.
Some people taking prucalopride have reported suicidal thoughts or behavior, thoughts of self-harm, or new or worsening depression, often within the first few weeks. It has not been shown that the medicine causes these problems, but anyone who notices an unusual change in mood or behavior, or suicidal thoughts, should stop taking it and contact the prescriber right away. Family members or caregivers can help by watching for such changes early in treatment. Prucalopride is not used when the bowel is blocked or torn, when the bowel muscle has stopped moving stool along (a condition called ileus), or with severe inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a severely swollen colon (toxic megacolon). Because it strengthens bowel contractions, using it in these situations could cause serious harm. Few medicines interact with it in a way that matters. Studies found no meaningful changes when it was taken with common drugs such as warfarin, digoxin, certain antidepressants and birth control pills. There is limited information on use in pregnancy, and prucalopride passes into breast milk, so people who are pregnant, planning pregnancy or breastfeeding should weigh it with their prescriber.
Many people notice a difference quickly. In clinical trials, bowel movements became more frequent within the first week, and people on prucalopride usually had their first complete bowel movement within a few days of starting, compared with one to three weeks on placebo. The effect lasted through the 12 weeks most trials ran. It does not work for everyone. In those trials, roughly 2 or 3 in 10 people taking prucalopride reached at least three complete bowel movements a week (meaning ones that left a feeling of being fully emptied), compared with about 1 to 2 in 10 on placebo. Trials also found improvements in straining, abdominal discomfort and quality of life compared with placebo. Checking in with the prescriber after a few weeks helps decide whether it is worth continuing. There is no set limit on how long it can be taken, although the trials lasted up to 24 weeks.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Motegrity (Prucalopride), what you've noticed, or ask the community a question.